Depression Treatment Maplewood, NJ

You can start with a free 15-minute call, without an insurance hurdle or intake paperwork first, and get clear information on options such as SSRIs and other antidepressants, therapy support, safety planning, depression during pregnancy, seasonal patterns, treatment-resistant depression, coordination with other mental health or addiction care, and insurance or sliding-scale payment questions. Depression can disrupt sleep, work, school, relationships, and day-to-day functioning, but it is treatable, and getting the right plan in place early can make sustained relief more likely.

Book a free 15-min call→

• APA + AAFP guideline–aligned

• PHQ-9 measurement-based care

• Telehealth across New Jersey

Depression is not sadness. It is a medical condition with observable symptoms — low mood that lasts most of the day nearly every day for at least two weeks, loss of interest in things you used to care about, changes in appetite and difficulty sleeping, cognitive slowing, worthless thinking, and in some cases suicidal thoughts. The DSM-5-TR codifies nine criteria, of which five (including one of the first two) are required for a major depressive episode diagnosis. That structural definition matters because it separates depression from the normal difficulty of a hard season in everyday life.

Roughly 1 in 10 US adults experience a major depressive episode in any given year, and depression often runs longer and feels heavier than people expect. It is treatable. Most clients respond to a combination of medication and psychotherapy within 6–12 weeks, and most achieve sustained remission with the right plan. The barrier to good outcomes is rarely whether depression responds to treatment — it usually does — but whether the treatment was actually matched to the patient, adjusted promptly, and sustained long enough.

This page is the long-form version of what an initial depression visit covers at our Maplewood, NJ office and over NJ-wide telehealth: what depression is and isn't, which medications are first-line and why, what the evidence says about therapy alongside medication, what to do when the first medication doesn't work, how long treatment lasts, how to stop safely, and the specific forms of depression that need slightly different plans.

Major depressive disorder (MDD) is the most common presentation — episodes lasting weeks to months with the full symptom cluster, often recurrent. Persistent depressive disorder (PDD, formerly dysthymia) is a chronic low-grade depression lasting two years or more with fewer acute symptoms but significant functional impact on daily responsibilities. Premenstrual dysphoric disorder (PMDD) is a cyclical, hormone-linked depression pattern in the week before menstruation. Disruptive mood dysregulation disorder (DMDD) applies to children and early adolescents with chronic irritability and outburst patterns; it is not within our scope for patients under 12.

Postpartum depression affects roughly 1 in 8 mothers and is distinct from the self-limiting "baby blues" that pass within two weeks. Prenatal depression is equally common and often under-detected because clinicians hesitate to prescribe during pregnancy. Seasonal affective disorder (SAD) is the winter-onset variant that responds to both light therapy and standard antidepressants. Atypical depression presents with hypersomnia, increased appetite, mood reactivity, and interpersonal rejection sensitivity. Bipolar depression — the depressive phase of bipolar I or II — looks similar on the surface but requires mood stabilizer coverage before any antidepressant is started to prevent a switch into mania.

Getting the subtype right changes the treatment plan materially. A patient with treatment-resistant MDD gets different next steps than a patient whose "treatment-resistant MDD" is actually unrecognized bipolar II. A patient with winter-only depressive episodes may only need a 10,000-lux light box and no medication. We take the time during evaluation to determine which picture we are actually looking at.

The AAFP's 2023 pharmacologic guideline identifies escitalopram, mirtazapine, paroxetine, venlafaxine, and amitriptyline as the most effective antidepressants in head-to-head trials. Here's how we actually pick one.

SSRIs

Selective serotonin reuptake inhibitors — sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), citalopram (Celexa), paroxetine (Paxil) — are first-line for most adults with major depression. They have the best long-term safety record of any antidepressant class and the shortest list of dangerous drug interactions. Escitalopram has the cleanest tolerability profile for most clients; sertraline is preferred when you want flexibility to raise the dose; fluoxetine's long half-life makes it the easiest to stop. Paroxetine works well but has the most pronounced discontinuation syndrome. Citalopram has a dose ceiling of 40 mg/day in adults (20 mg in patients over 60) due to QT-interval concerns.

SNRIs

Serotonin-norepinephrine reuptake inhibitors — venlafaxine (Effexor XR), duloxetine (Cymbalta) — are second-line choices when SSRIs haven't worked or when comorbid chronic pain, fibromyalgia, or peripheral neuropathy is part of the clinical picture. Duloxetine has FDA indications across depression, generalized anxiety, and chronic musculoskeletal pain, which makes it useful when anxiety and depression arrive together. Venlafaxine has the most potent antidepressant effect in the AAFP head-to-head data but also the harshest discontinuation syndrome of any common antidepressant — if we start venlafaxine, we tell you explicitly what stopping will require.

Atypical antidepressants

Bupropion (Wellbutrin) works on dopamine and norepinephrine rather than serotonin. It is energizing rather than sedating, does not cause sexual side effects or weight gain, and can be useful in patients with ADHD-like focus complaints alongside depression. It is contraindicated in seizure disorders and active eating disorders. Mirtazapine (Remeron) is useful for depression with prominent insomnia and appetite loss; it is sedating at lower doses and weight-promoting at higher doses. Trazodone is rarely used as a primary antidepressant today — it is more commonly prescribed at low dose for insomnia.

When to switch vs. augment

About one-third of patients respond to the first SSRI. If yours doesn't by 6–8 weeks at an adequate dose, we choose between switching to a different first-line agent and augmenting the current one with a second medication (bupropion, mirtazapine, lithium, or a low-dose atypical antipsychotic like aripiprazole). The choice depends on how much of a partial response you had, whether side effects were tolerable, and your treatment goals. Neither path is wrong; we walk through both and decide together.

This is a solo outpatient practice, not a full continuum of care. Being explicit about that saves people weeks.

What happens here: outpatient services covering psychiatric evaluation, diagnosis, medication management, brief supportive therapy, safety planning, coordination with your therapist and primary care, and ongoing outpatient treatment at whatever interval your depression requires. These are the only mental health services this clinic provides directly.

What we refer out:

• Intensive outpatient program. An intensive outpatient program (IOP) runs several hours a day, several days a week, and suits depression that is too severe for weekly outpatient services but does not need a hospital bed. We do not run an IOP. When one is indicated we say so and help you find one.

• Partial hospitalization and residential treatment. Residential treatment and residential care for severe depression exist across New Jersey. We refer rather than stretch outpatient care past what it can safely hold.

• Inpatient care. For acute safety concerns, the right answer is a hospital, not a follow-up appointment.

• Group therapy. Group therapy has good evidence for depression, but it is not offered here. NAMI-NJ runs free peer groups, and several NJ treatment centers offer clinician-led groups.

• ECT, TMS, ketamine, and esketamine. Covered in detail below.

• Detox and addiction treatment. We do not provide detox, medication assisted treatment, or substance use rehabilitation. See the section below.

New Jersey has a wide range of mental health programs, from hospital-affiliated treatment programs to private treatment centers to county behavioral health services. The programs differ enormously in intensity, cost, and what insurance will pay for, and the websites rarely make that clear.

If you are comparing treatment centers and outpatient clinics and cannot tell which level you need, the free 15-minute call is a reasonable place to sort that out, even if the answer turns out to be somewhere other than here. We would rather spend fifteen minutes pointing you at the right programs than enroll you in the wrong services.

For depression that hasn't responded to two or more adequate medication trials, four advanced options sit on the shelf. Electroconvulsive therapy (ECT) remains the most effective treatment for severe, treatment-resistant, psychotic, or catatonic depression — response rates are 70–90% when it's appropriately indicated. Modern ECT with unilateral electrode placement and ultrabrief pulse parameters has dramatically improved the cognitive side-effect profile from the version portrayed in older media. Transcranial magnetic stimulation (TMS) is a non-invasive office-based treatment with a 30–60% response rate, typically delivered as 20–30 daily sessions over 4–6 weeks. Ketamine (IV) and esketamine (Spravato intranasal, FDA-approved, REMS-restricted) are rapid-acting treatment options for treatment-resistant depression with documented response within 24–72 hours.

We don't provide ECT, TMS, or ketamine/esketamine in-house. That's a transparency point: these are specialized procedures requiring facility-based delivery, specific certifications, and in the case of Spravato, REMS program enrollment. What we do is identify when a patient is a candidate, discuss the evidence and trade-offs honestly, refer to New Jersey programs we trust, and continue coordinating medication management in parallel. You don't lose your psychiatric care when you go to a procedure; we stay on your team.

When the time comes to stop an antidepressant, the taper matters. Abruptly discontinuing SSRIs or SNRIs produces an identifiable syndrome captured by the FINISH mnemonic: Flu-like symptoms, Insomnia, Nausea, Imbalance (dizziness), Sensory disturbances ("brain zaps" are the classic one), and Hyperarousal. It is uncomfortable but not medically dangerous, and it is entirely preventable with a gradual taper.

The standard taper reduces the dose by 25% every 4 weeks, or by 12.5% every 2 weeks for the agents with the harshest withdrawal symptoms (venlafaxine, paroxetine). Fluoxetine, with its weeks-long half-life, essentially auto-tapers itself and can often be stopped from 20 mg without issue. We build the specific taper schedule to your medication, duration of use, and prior response patterns. If withdrawal symptoms emerge, we pause at the current step, give the body time, and proceed more slowly — we do not push through.

Tapering off is not the same as tapering because it's time to stop. Some patients relapse during or shortly after discontinuation — the symptoms are not withdrawal, they are depression returning. We watch carefully for the first 6–8 weeks after discontinuation and are prepared to restart promptly, without the moralized shame that sometimes accompanies "I couldn't come off." Needing medication is not a failure; it is sometimes how the illness is structured.

Seasonal affective disorder (SAD) is a depressive pattern that emerges in fall and winter and remits in spring, tied to reduced daylight hours. In New Jersey latitudes, onset is typically late October through February and remission is usually by late March. The pattern is distinct enough in most patients that a prior-year history plus a current fall presentation is effectively diagnostic. SAD affects an estimated 5% of adults, with a further 10–20% experiencing milder winter-pattern symptoms that don't meet full criteria.

Bright light therapy is first-line for SAD. A 10,000-lux full-spectrum light box used for 20–30 minutes within an hour of waking produces response within one to two weeks for most clients. The lux specification matters — a 2,500-lux box requires much longer exposure and is less well-evidenced. Standard antidepressants (SSRIs, bupropion XL) are equally effective when light therapy is not tolerated or when the depression is severe. Some clients use both, starting the light box in early October and adding an antidepressant if symptoms break through. For established recurrent-SAD patients, we often discuss starting the light box prophylactically before typical onset rather than waiting for symptoms.

Every depression patient at our clinic starts with a 60–90-minute comprehensive evaluation. That visit produces a DSM-5-TR diagnosis (or a clear working differential), a PHQ-9 baseline, a medical workup plan if one is indicated, and an explicit treatment plan we build together. If medication is indicated and you're comfortable starting, the prescription goes out the same day. If therapy is indicated and you don't already have a therapist, we hand you two or three concrete New Jersey referrals with openings.

Follow-up visits are not 15 minutes. We schedule 30 minutes for medication management and 45 for medication-plus-supportive-therapy visits, which is where most of the actual work of staying on a plan happens — side-effect troubleshooting, motivation when the first weeks are hard, and honest recalibration when something isn't working. The PHQ-9 is re-administered at most visits; measurement-based care makes dose decisions clearer and makes "I feel about the same" measurable. Drug interactions are re-checked at every visit, and the mental health services here include coordination with your pharmacy and primary care.

Teresa is a Board-Certified Psychiatric Mental Health Nurse Practitioner treating adults, young adults, adolescents, and older adults across NJ, and anxiety is the condition that most often arrives alongside depression in this practice. The aim is a supportive environment and compassionate support rather than a fifteen-minute conveyor belt — enough time in the room that the plan is actually yours, and enough continuity that the mental health care does not restart from zero every visit.

If depression co-occurs with anxiety, ADHD, bipolar II, PTSD, trauma, or substance use — which is the rule, not the exception — we manage the full picture together rather than fragmenting it across specialists. One plan, one record, one relationship.

Family history matters at intake — depression, bipolar disorder, and anxiety cluster in families, and a family pattern of response to a particular medication is genuinely useful information. With your written consent, a family member can join a visit or be kept updated on the plan. For adolescents, family involvement is standard.

How do I know if I'm depressed or just sad?

Sadness is proportionate, finite, and responds to good things happening. Depression persists most of the day, nearly every day, for two weeks or more, and it does not lift when something good happens. The tell is usually anhedonia — losing interest in things you used to enjoy — plus changes in sleep, appetite, concentration, and energy. The PHQ-9 puts a number on it, but functional impact is the real dividing line.

Do I need medication, or can therapy alone work?

Therapy alone works for many people with mild to moderate depression, and it has the advantage of durable skills. Medication alone also works. For moderate to severe depression the combination outperforms either on its own. You are not obligated to take anything — we lay out the treatment options and you decide.

How long do antidepressants take to work?

Two to four weeks for the first noticeable change, six to eight weeks at an adequate dose for full effect. Sleep and appetite often improve before mood does. If nothing has shifted by week eight at a proper dose, that is information, and we change course rather than wait.

What are the side effects of antidepressants?

Most common early: nausea, headache, jitteriness, and sleep changes in the first one to two weeks, which usually settle. Longer-term, the ones clients actually stop over are sexual side effects and weight change. Both are manageable — often by switching agent rather than quitting treatment. We ask about them directly, because most people will not raise them unprompted.

How long will I have to take antidepressants?

For a single first episode, typically 9–12 months of stable remission before a supervised taper. For recurrent depression — two or more prior episodes — longer maintenance meaningfully reduces recurrence. This gets re-evaluated at every visit, not decided once.

What if my first antidepressant doesn't work?

Roughly a third of clients respond to the first SSRI, which means two-thirds need a second step. That is normal and expected, not failure. We either switch agents or augment with a second medication, depending on whether you had a partial response and how the side effects were.

Is ketamine treatment safe, and do you offer it?

Ketamine and esketamine are well-studied for treatment-resistant depression with response often within 24–72 hours, delivered under monitoring in certified settings. We do not offer either. If you are a candidate we will say so and refer to a New Jersey program.

Can I treat depression during pregnancy safely?

Usually yes, and untreated perinatal depression carries its own documented risks. Sertraline and escitalopram have the largest reassuring datasets in pregnancy and lactation. The decision is individual and made with your obstetric provider, not in isolation.

What's the difference between depression and seasonal affective disorder?

SAD is depression with a seasonal pattern — fall and winter onset, spring remission, repeating across years. That pattern matters because light therapy is first-line for SAD and is not first-line for non-seasonal depression.

How do I stop antidepressants without the withdrawal symptoms?

Taper gradually, typically 25% every four weeks, slower for venlafaxine and paroxetine. Never stop abruptly. If withdrawal symptoms appear we pause and slow down rather than push through.

What are the treatment options for severe depression?

Severe depression usually needs medication plus therapy from the start rather than a stepwise trial. If two adequate medication trials fail, treatment options widen to augmentation, ECT, TMS, or esketamine. If safety is a concern, an intensive outpatient program, partial hospitalization, or inpatient care is the right level rather than weekly outpatient visits. We help determine which.

What should I do if I feel too depressed to get out of bed?

That is a symptom, not a character failure, and it is one of the more treatable ones. In the short term, shrink the target: get upright, open a curtain, drink water. Then tell someone — a loved one, your primary care provider, or us. If you are having thoughts of ending your life, call or text 988 now. If you can manage one phone call today, make it the free 15-minute call; we can work with less than you think you need to bring.

When therapy doesn't work for depression?

First check whether the therapy was an adequate trial — the right modality, a therapist you could actually talk to, and enough sessions. If it was, adding medication is the usual next step, since combination treatment outperforms either alone. It is also worth re-examining the diagnosis: bipolar II, ADHD, trauma, thyroid disease, and heavy alcohol use all masquerade as treatment-resistant depression.

Is Maplewood, NJ a wealthy town?

By most measures, yes. Census figures put median household income in Maplewood township at $173,500, well above the New Jersey and national medians. It comes up on a page like this because people assume an affluent town does not need accessible mental health services, and that assumption is wrong in both directions. Depression does not track income — it is roughly as common in high-earning households as anywhere else, and the pressure to appear fine can be higher where everyone looks fine. And the averages hide people: 3.3% of Maplewood residents live below the poverty line, and about 4% of residents under 65 have no health insurance at all. That is why this clinic publishes its prices and offers a sliding scale rather than quoting rates only on the phone.